Pinex Major 1000 mg / 60 mg Norwegia - Norwegia - Statens legemiddelverk

pinex major 1000 mg / 60 mg

actavis group ptc ehf (1) - paracetamol / kodeinfosfathemihydrat - stikkpille - 1000 mg / 60 mg

Pantoprazol Pensa 20 mg Norwegia - Norwegia - Statens legemiddelverk

pantoprazol pensa 20 mg

pensa pharma ab - pantoprazolnatriumsesquihydrat - enterotablett - 20 mg

Pantoprazol Pensa 40 mg Norwegia - Norwegia - Statens legemiddelverk

pantoprazol pensa 40 mg

pensa pharma ab - pantoprazolnatriumsesquihydrat - enterotablett - 40 mg

Provaqomyl 250 mg / 100 mg Norwegia - Norwegia - Statens legemiddelverk

provaqomyl 250 mg / 100 mg

viatris limited - atovakvon / proguanilhydroklorid - tablett, filmdrasjert - 250 mg / 100 mg

Pepcid 10 mg Norwegia - Norwegia - Statens legemiddelverk

pepcid 10 mg

mcneil sweden ab - famotidin - tablett, filmdrasjert - 10 mg

Phenoleptil 25 mg Norwegia - Norwegia - Statens legemiddelverk

phenoleptil 25 mg

dechra regulatory b.v. - fenobarbital - tablett - 25 mg

Phenoleptil 100 mg Norwegia - Norwegia - Statens legemiddelverk

phenoleptil 100 mg

dechra regulatory b.v. - fenobarbital - tablett - 100 mg

Ranitidin ratiopharm 150 mg Norwegia - Norwegia - Statens legemiddelverk

ranitidin ratiopharm 150 mg

ratiopharm gmbh - ranitidinhydroklorid - tablett, filmdrasjert - 150 mg

Ranitidin ratiopharm 300 mg Norwegia - Norwegia - Statens legemiddelverk

ranitidin ratiopharm 300 mg

ratiopharm gmbh - ranitidinhydroklorid - tablett, filmdrasjert - 300 mg

Zejula Uni Eropa - Norwegia - EMA (European Medicines Agency)

zejula

glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - antineoplastiske midler - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.